| Source | Code | Name | Case count | Share of cases (%) |
|---|---|---|---|---|
| OUTPAT | OUTPAT_ICD10(C811) | Nodular sclerosis | 389 | |
| INPAT | INPAT_ICD10(C811) | Nodular sclerosis | 249 | |
| OUTPAT | OUTPAT_ICD10(C819) | Hodgkin's disease, unspecified | 247 | |
| INPAT | INPAT_ICD10(C819) | Hodgkin's disease, unspecified | 171 | |
| OUTPAT | OUTPAT_ICD10(C810) | Lymphocytic predominance | 149 | |
| OUTPAT | OUTPAT_ICD10(C812) | Mixed cellularity | 112 | |
| OUTPAT | OUTPAT_ICD10(C817) | Other Hodgkin's disease | 109 | |
| INPAT | INPAT_ICD10(C810) | Lymphocytic predominance | 77 | |
| INPAT | INPAT_ICD10(C812) | Mixed cellularity | 68 | |
| INPAT | INPAT_ICD10(C817) | Other Hodgkin's disease | 53 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(C811) | Nodular sclerosis. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 50 | |
| INPAT | INPAT_ICD9(2015X) | Hodgkin's disease, Nodular sclerosis | 42 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(C819) | Hodgkin's disease, unspecified. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 35 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(C81) | Hodgkin's disease. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 28 | |
| INPAT | INPAT_ICD9(2019X) | Hodgkin's disease, unspecified type | 27 | |
| OUTPAT | OUTPAT_ICD10(C813) | Lymphocytic depletion | 22 | |
| INPAT | INPAT_ICD9(2016A) | Hodgkin's disease, mixed cellularity | 19 | |
| INPAT | INPAT_ICD9(2014A) | Hodgkin's disease, Lymphocytic-histiocytic predominance | 18 | |
| DEATH | DEATH_ICD10(C811) | Nodular sclerosis | 15 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(C817) | Other Hodgkin's disease. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 14 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(C812) | Mixed cellularity. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 12 | |
| INPAT | INPAT_ICD10(C813) | Lymphocytic depletion | 11 | |
| INPAT | INPAT_ICD9(2015A) | Hodgkin's disease, Nodular sclerosis | 11 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(C810) | Lymphocytic predominance. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 11 | |
| DEATH | DEATH_ICD10(C819) | Hodgkin's disease, unspecified | 8 | |
| INPAT | INPAT_ICD9(2014X) | Hodgkin's disease, Lymphocytic-histiocytic predominance | 7 | |
| INPAT | INPAT_ICD9(2017X) | Hodgkin's disease, Lymphocytic depletion | 7 | |
| OUTPAT | OUTPAT_ICD10(C81) | Hodgkin's disease | 6 |